*<p>Extended follow-up, including PFS values, were available for 99 patients.</p
<p>Clinical characteristics of the study patients at the time of first recurrence.</p
<p>Data regarding number of patients included, treated according to protocol and followed up at 21 a...
<p>Demographic and clinical characteristics of the included patients (n = 400).</p
<p>Characteristics at baseline and at follow-up of the patients included in the study.</p
<p>Patients’ characteristics for the baseline (<i>n</i> = 154) and follow-up (<i>n</i> = 116) survey...
Patients’ and treatment characteristics and clinical outcomes for overall group and matched group af...
<p>Clinical characteristics and study outcomes of patients at baseline and follow up.</p
Patient and doctor characteristics at baseline, 6-month follow-up (trial endline), and 18-month foll...
<p>ARR: annualized relapse rate; EDSS: expanded disability status scale</p><p>Clinical characteristi...
<p>Characteristics for all patients and for responders and non-responders at baseline and during fol...
<p>Characteristics of patients included in the analysis of recurrences (N = 303 on first admission)....
Baseline clinical characteristics of patients who were followed up for 6 months.</p
<p>*available in 39 patients (i.e., 13 patients in stage 2A, 14 in stage 2B and 12 in stage 3)</p><p...
<p>Patients' baseline characteristics, medical history, and medication use during the follow-up.</p
Characteristics of patients who experienced liver or cardiovascular related events during follow up....
<p>Clinical characteristics of the study patients at the time of first recurrence.</p
<p>Data regarding number of patients included, treated according to protocol and followed up at 21 a...
<p>Demographic and clinical characteristics of the included patients (n = 400).</p
<p>Characteristics at baseline and at follow-up of the patients included in the study.</p
<p>Patients’ characteristics for the baseline (<i>n</i> = 154) and follow-up (<i>n</i> = 116) survey...
Patients’ and treatment characteristics and clinical outcomes for overall group and matched group af...
<p>Clinical characteristics and study outcomes of patients at baseline and follow up.</p
Patient and doctor characteristics at baseline, 6-month follow-up (trial endline), and 18-month foll...
<p>ARR: annualized relapse rate; EDSS: expanded disability status scale</p><p>Clinical characteristi...
<p>Characteristics for all patients and for responders and non-responders at baseline and during fol...
<p>Characteristics of patients included in the analysis of recurrences (N = 303 on first admission)....
Baseline clinical characteristics of patients who were followed up for 6 months.</p
<p>*available in 39 patients (i.e., 13 patients in stage 2A, 14 in stage 2B and 12 in stage 3)</p><p...
<p>Patients' baseline characteristics, medical history, and medication use during the follow-up.</p
Characteristics of patients who experienced liver or cardiovascular related events during follow up....
<p>Clinical characteristics of the study patients at the time of first recurrence.</p
<p>Data regarding number of patients included, treated according to protocol and followed up at 21 a...
<p>Demographic and clinical characteristics of the included patients (n = 400).</p
DOI
Add to ORKG